32 results
P
patients undergoing VA-ECMO
I/C
mechanical LV unloading, afterload reduction (IABP) vs. preload reduction (Impella pump, right upper pulmonary/trans-septal catheters, LV surgical vents)
O
in-hospital death
P
subclinical hypothyroidism (ScH) patients
I/C
left ventricular (LV) function evaluation, healthy individuals
O
significantly worse LV function parameters
P
stroke patients
I/C
intravenous thrombolysis (IVT), normal weight, non-obesity, non-overweight
O
3-mo poor functional outcome, 3-mo mortality
P
children with type one diabetes mellitus (T1DM)
I/C
two-dimensional speckle tracking echocardiography, healthy controls
O
subclinical myocardial insults, LV global longitudinal strain (LVGLS), LV global circumferential strain (LVGCS)
P
hospital teams
I/C
Quality Improvement (QI) processes
O
increasing adherence to safe infant sleep recommendations
P
CRT recipients
I/C
electrically- or imaging-guided LV lead positioning, routine
O
all-cause mortality and heart failure hospitalization, 6MWT distance
P
patients
I/C
LV myocardial strain variables, no intervention
O
major adverse cardiovascular events (MACE)
P
dilated cardiomyopathy patients
I/C
Cardiac magnetic resonance (CMR) derived left ventricular global longitudinal strain (LV-GLS), mortality
O
major adverse cardiac events
P
209 participants
I/C
CARILLON® mitral contour system, control
O
MR severity, LA volume, LV remodelling, EDV, ESV, LVEF, New York Heart Association functional Class, HFH rates
P
abiraterone, enzalutamide, apalutamide, docetaxel
I/C
combination therapy, hormonal treatments, chemotherapy, abiraterone vs. docetaxel, enzalutamide vs. docetaxel
O
overall survival (OS), median OS duration